SCHEMBL23674099

SCHEMBL23674099

CCCCCCc1ccc2[nH]c(=O)c(C)c(-c3ccccc3)c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSV O60911 3/20 0.50
▸ CTSL P07711 3/20 0.50
▸ HSD17B10 Q99714 4/20 0.48
▸ KDM4E B2RXH2 3/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ HPGD P15428 2/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.47
▸ GAA P10253 1/20 0.46
▸ MAPT P10636 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ ADORA1 P30542 1/20 0.45
▸ PIM1 P11309 1/20 0.45
▸ RAB9A P51151 1/20 0.44
▸ PARP1 P09874 2/20 0.44
▸ SERPINE1 P05121 1/20 0.44
▸ CSF1R P07333 1/20 0.43
▸ PTGES O14684 1/20 0.43
▸ TSHR P16473 1/20 0.42
▸ RORA P35398 1/20 0.42
▸ RORC P51449 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20227724 0.81 CTSV (0.51) CTSVCTSLHSD17B10KDM4EALDH1A1
SCHEMBL23674337 0.80 HSD17B10 (0.55) CTSVCTSLHSD17B10KDM4EALDH1A1
SCHEMBL23674280 0.79 MEN1 (0.53) CTSVCTSLKDM4EALDH1A1HPGD
SCHEMBL22910882 0.76 KDM4E (0.65) HSD17B10KDM4EALDH1A1HPGDNPSR1
SCHEMBL12795553 0.74 HTR1A (0.57) CTSVCTSLHSD17B10KDM4EALDH1A1
SCHEMBL1128166 0.74 HTR1A (0.57) CTSVCTSLHSD17B10KDM4EALDH1A1
SCHEMBL12100781 0.74 HTR1A (0.57) CTSVCTSLHSD17B10KDM4EALDH1A1
SCHEMBL31410497 0.74 HTR1A (0.57) CTSVCTSLHSD17B10KDM4EALDH1A1
SCHEMBL4581413 0.74 HTR1A (0.57) CTSVCTSLHSD17B10KDM4EALDH1A1
SCHEMBL31070057 0.74 HTR1A (0.57) CTSVCTSLHSD17B10KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115209883-B Novel cell metabolism regulating compound and use thereof 新月生物科学 2025-05-20 — — CN disclosed
US-20230183179-A1 NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF CRESCENTA BIOSCIENCES (US) 2023-06-15 — — US disclosed
US-20230183179-A1 NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF CRESCENTA BIOSCIENCES (US) 2023-06-15 — — US disclosed
US-20230183179-A1 NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF CRESCENTA BIOSCIENCES (US) 2023-06-15 — — US disclosed
EP-4093384-A1 NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF Crescenta Biosciences (US) 2022-11-30 — — EP disclosed
CN-115209883-A Novel cell metabolism-regulating compounds and uses thereof 新月生物科学 2022-10-18 — — CN disclosed
WO-2021150645-A1 NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF CRESCENTA BIOSCIENCES (US) 2021-07-29 — — WO disclosed
WO-2021150645-A1 NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF CRESCENTA BIOSCIENCES (US) 2021-07-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183179-A1 NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF FABP4, FABP1, FABP3 CTSV 2053/4885CTSL 1505/4885HSD17B10 264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback